RENAISSANCE TECHNOLOGIES LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1037389
NEW YORK, NY
Position in MRVI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,069,069
-$1,662,470 QoQ
Shares Held
4,264,689
+0.9% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,447,997,584 across 326 Biotechnology names. MRVI ranks #42 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in MRVI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,069,069 | 4,264,689 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,731,539 | 4,225,089 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,392,915 | 4,318,089 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,088,715 | 4,186,189 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,084,622 | 4,110,689 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,648,430 | 3,972,189 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,390,727 | 4,138,475 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $27,791,117 | 3,881,441 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $27,855,747 | 3,212,889 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $18,901,262 | 2,885,689 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,596,890 | 2,659,689 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,343,805 | 2,441,175 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $44,726,925 | 3,192,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $47,608,625 | 3,326,948 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $38,874,531 | 1,522,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $53,268,750 | 1,875,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $32,208,564 | 913,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $22,827,120 | 544,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $46,629,975 | 950,081 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $26,907,504 | 644,800 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||